Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

被引:66
作者
Sinn, Hans-Peter [1 ]
Schneeweiss, Andreas [2 ]
Keller, Marius [1 ]
Schlombs, Kornelia [6 ]
Laible, Mark [6 ]
Seitz, Julia [2 ]
Lakis, Sotirios [4 ]
Veltrup, Elke [4 ]
Altevogt, Peter [3 ]
Eidt, Sebastian [5 ]
Wirtz, Ralph M. [4 ,5 ]
Marme, Frederik [2 ]
机构
[1] Heidelberg Univ, Inst Pathol, Neuenheimer Feld 220-221, D-69120 Heidelberg, Germany
[2] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Neuenheimer Feld 460, D-69120 Heidelberg, Germany
[3] German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[4] STRATIFYER Mol Pathol GmbH, Werthmannstr 1c, D-50935 Cologne, Germany
[5] St Elizabeth Hosp, Dept Pathol, Werthmannstr 1c, D-50935 Cologne, Germany
[6] BioNTech Diagnost GmbH, D-55131 Mainz, Germany
来源
BMC CANCER | 2017年 / 17卷
关键词
Image analysis; Breast cancer; Ki67; mRNA; RT-qPCR; Prediction; Pathologic complete response; neoadjuvant; Immunohistochemistry (IHC); MammaTyper (R); INTERNATIONAL EXPERT CONSENSUS; ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; AUTOMATED ASSESSMENT; MOLECULAR SUBTYPES; PROGNOSTIC VALUE; CORE BIOPSIES; KI67; NEOADJUVANT; EXPRESSION;
D O I
10.1186/s12885-017-3111-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Proliferation may predict response to neoadjuvant therapy of breast cancer and is commonly assessed by manual scoring of slides stained by immunohistochemistry (IHC) for Ki-67 similar to ER and PgR. This method carries significant intra- and inter-observer variability. Automatic scoring of Ki-67 with digital image analysis (qIHC) or assessment of MKI67 gene expression with RT-qPCR may improve diagnostic accuracy. Methods: Ki-67 IHC visual assessment was compared to the IHC nuclear tool (AperioTM) on core biopsies from a randomized neoadjuvant clinical trial. Expression of ESR1, PGR and MKI67 by RT-qPCR was performed on RNA extracted from the same formalin-fixed paraffin-embedded tissue. Concordance between the three methods (vIHC, qIHC and RT-qPCR) was assessed for all 3 markers. The potential of Ki-67 IHC and RT-qPCR to predict pathological complete response (pCR) was evaluated using ROC analysis and non-parametric Mann-Whitney Test. Results: Correlation between methods (qIHC versus RT-qPCR) was high for ER and PgR (spearman's r = 0.82, p < 0.0001 and r = 0.86, p < 0.0001, respectively) resulting in high levels of concordance using predefined cut-offs. When comparing qIHC of ER and PgR with RT-qPCR of ESR1 and PGR the overall agreement was 96.6 and 91.4%, respectively, while overall agreement of visual IHC with RT-qPCR was slightly lower for ER/ESR1 and PR/PGR (91.2 and 92.9%, respectively). In contrast, only a moderate correlation was observed between qIHC and RT-qPCR continuous data for Ki-67/MKI67 (Spearman's r = 0.50, p = 0.0001). Up to now no predictive cut-off for Ki-67 assessment by IHC has been established to predict response to neoadjuvant chemotherapy. Setting the desired sensitivity at 100%, specificity for the prediction of pCR (ypT0ypN0) was significantly higher for mRNA than for protein (68.9% vs. 22.2%). Moreover, the proliferation levels in patients achieving a pCR versus not differed significantly using MKI67 RNA expression (Mann-Whitney p = 0.002), but not with qIHC of Ki-67 (Mann-Whitney p = 0.097) or vIHC of Ki-67 (p = 0.131). Conclusion: Digital image analysis can successfully be implemented for assessing ER, PR and Ki-67. IHC for ER and PR reveals high concordance with RT-qPCR. However, RT- qPCR displays a broader dynamic range and higher sensitivity than IHC. Moreover, correlation between Ki-67 qIHC and RT-qPCR is only moderate and RT-qPCR with MammaTyper (R) outperforms qIHC in predicting pCR. Both methods yield improvements to error-prone manual scoring of Ki-67. However, RT-qPCR was significantly more specific.
引用
收藏
页数:10
相关论文
共 43 条
  • [1] High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
    Abubakar, Mustapha
    Howat, William J.
    Daley, Frances
    Zabaglo, Lila
    McDuffus, Leigh-Anne
    Blows, Fiona
    Coulson, Penny
    Ali, H. Raza
    Benitez, Javier
    Milne, Roger
    Brenner, Herman
    Stegmaier, Christa
    Mannermaa, Arto
    Chang-Claude, Jenny
    Rudolph, Anja
    Sinn, Peter
    Couch, Fergus J.
    Tollenaar, Rob A. E. M.
    Devilee, Peter
    Figueroa, Jonine
    Sherman, Mark E.
    Lissowska, Jolanta
    Hewitt, Stephen
    Eccles, Diana
    Hooning, Maartje J.
    Hollestelle, Antoinette
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    Bolla, Manjeet K.
    Wang, Qin
    Jones, Michael
    Schoemaker, Minouk
    Broeks, Annegien
    van Leeuwen, Flora E.
    Van't Veer, Laura
    Swerdlow, Anthony J.
    Orr, Nick
    Dowsett, Mitch
    Easton, Douglas
    Schmidt, Marjanka K.
    Pharoah, Paul D.
    Garcia-Closas, Montserrat
    [J]. JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2016, 2 (03): : 138 - 153
  • [2] Berruti Alfredo, 2011, Journal of the National Cancer Institute Monographs, P147, DOI 10.1093/jncimonographs/lgr037
  • [3] RNA Extraction from Archival Formalin-Fixed Paraffin-Embedded Tissue: A Comparison of Manual, Semiautomated, and Fully Automated Purification Methods
    Bohmann, Kerstin
    Hennig, Guido
    Rogel, Uwe
    Poremba, Christopher
    Mueller, Berit Maria
    Fritz, Peter
    Stoerkel, Stephan
    Schaefer, Karl-L.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (09) : 1719 - 1727
  • [4] Intrinsic breast cancer subtypes defined by estrogen receptor signalling-prognostic relevance of progesterone receptor loss
    Braun, Lisa
    Mietzsch, Friederike
    Seibold, Petra
    Schneeweiss, Andreas
    Schirmacher, Peter
    Chang-Claude, Jenny
    Sinn, Hans Peter
    Aulmann, Sebastian
    [J]. MODERN PATHOLOGY, 2013, 26 (09) : 1161 - 1171
  • [5] Cass Jamaica D, 2012, Cancers (Basel), V4, P725, DOI 10.3390/cancers4030725
  • [6] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
    Cheang, Maggie C. U.
    Chia, Stephen K.
    Voduc, David
    Gao, Dongxia
    Leung, Samuel
    Snider, Jacqueline
    Watson, Mark
    Davies, Sherri
    Bernard, Philip S.
    Parker, Joel S.
    Perou, Charles M.
    Ellis, Matthew J.
    Nielsen, Torsten O.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10): : 736 - 750
  • [7] Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
    Coates, A. S.
    Winer, E. P.
    Goldhirsch, A.
    Gelber, R. D.
    Gnant, M.
    Piccart-Gebhart, M.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (08) : 1533 - 1546
  • [8] Use and misuse of the receiver operating characteristic curve in risk prediction
    Cook, Nancy R.
    [J]. CIRCULATION, 2007, 115 (07) : 928 - 935
  • [9] Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer
    Cortazar, Patricia
    Geyer, Charles E., Jr.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) : 1441 - 1446
  • [10] Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
    Cuzick, Jack
    Dowsett, Mitch
    Pineda, Silvia
    Wale, Christopher
    Salter, Janine
    Quinn, Emma
    Zabaglo, Lila
    Mallon, Elizabeth
    Green, Andrew R.
    Ellis, Ian O.
    Howell, Anthony
    Buzdar, Aman U.
    Forbes, John F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) : 4273 - 4278